NATIONAL
CANCER
INSTITUTE

NCI Cancer Bulletin
A Trusted Source for Cancer Research News
February 22, 2005 • Volume 2 / Number 8 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe


Bulletin Home

Featured Article
Advisory Panel Weighs COX-2 Inhibitors' Fate

Director's Update
Health Information National Trends Survey Web Site Unveiled

Spotlight
Viruses Added to Federal List of Human Carcinogens

Cancer Research Highlights
Measles Virus Retargeted at Cancer Cells in Mice

Managed Care Growth Doesn't Sap Fee-for-Service Care Quality

Protein Test Could Detect Bladder Cancer Earlier

Researchers Develop Nanoprobes to Visualize Tumors Inside the Body

Symposium on Cancer Screening and Mortality at AAAS

Funding Opportunities

Featured Clinical Trial
Improving Allogeneic Stem Cell Transplantation

Notes
Gerhard Named OCG Director

Third Annual Cancer Survivorship Telephone Workshop Series

NCAB Quarterly Meeting Held

CCR Grand Rounds

Community Update
Cancer Research and Regulatory Fellowships Announced

Bulletin Archive

Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
Funding Opportunities

The following is a newly-released NCI research funding opportunity:

Specialized Programs of Research Excellence (SPOREs) in Human Cancer for Year 2005-2006
PAR-05-042
Letter of Intent Receipt Dates:
Lung and genitourinary (bladder, kidney, testicular, not prostate) cancer SPORE: Mar. 23, 2005; Skin and prostate cancer SPORE: July 23, 2005
Application Receipt Dates:
Lung and genitourinary (bladder, kidney, testicular, not prostate) cancer SPORE: May 23, 2005; Skin and prostate cancer SPORE: Sept. 23, 2005

This is a reissue of PAR-03-158, which was previously released Aug. 4, 2003. The Organ Systems Branch of the Office of Centers, Training, and Resources, NCI Office of the Director, invites grant applications for Specialized Programs of Research Excellence (SPOREs) in organ-specific cancers. A SPORE is supported through the specialized center (P50) grant mechanism.

For more information see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=2580. Inquiries: Dr. Jane Fountain - jf227t@nih.gov; Dr. Peter Ujhazy - pu5s@nih.gov; Dr. Andrew Hruszkewycz - ah5x@nih.gov.


For comprehensive information about NCI funding priorities and opportunities, go to http://www.cancer.gov/researchandfunding.

The NIH Roadmap for Medical Research Funding provides a framework of the priorities NIH must address to optimize its research portfolio. It identifies the most compelling opportunities in three main areas: new pathways to discovery, research teams of the future, and re-engineering the clinical research enterprise. Newly released Roadmap funding opportunities are listed below. For information on additional Roadmap funding opportunities, go to http://nihroadmap.nih.gov.

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov